| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1d60a93d4b13542095fea713d7770fd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate |
2005-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b970a4f0d91436c123c9e9f43e697bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0472dd5196f028f4112ecd20f3e10c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91ab6a28b3d4132a8a63e13b67761f84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28a96b72adf5f469276ef4562e6dcbc1 |
| publicationDate |
2006-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2006052232-A |
| titleOfInvention |
Human Toll-like receptor protein, related reagents and methods |
| abstract |
Novel soluble proteins that contribute to new therapies for a wide range of degenerative or abnormal conditions that are directly or indirectly involved in development, differentiation or function (eg, of the immune system and / or hematopoietic cells) And the discovery and development of novel receptors for lymphokines-like molecules that enhance or enhance the beneficial activity of other lymphokines, including the discovery and development of these and their receptors, including those similar to lymphokines Providing novel receptors and related compounds for ligands that show similarity to interleukin 1-like compositions, and methods for their use. A substantially pure or recombinant DTLR2 protein. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003533996-A |
| priorityDate |
1997-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |